美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

KraneShares Bosera MSCI China A 50 Connect Index ETF

23.71

-0.0300-0.13%

盤後：23.710.00000.00%16:08 EDT

成交量：1.78萬

成交額：42.40萬

市值：1.71億

市盈率：- -

高：23.78

開：23.78

低：23.71

收：23.74

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

【麗珠集團：擬15.87億元收購越南IMP公司64.81%股份】麗珠集團公告，公司境外全資附屬公司LIAN SGP HOLDING PTE.LTD.擬收購SK Investment Vina III Pte. Ltd.、Sunrise Kim Investment Joint Stock Company及KBA Investment Joint Stock Company合計持有的越南上市公司Imexpharm Corporation 64.81%股份，股權購買價格為57308.15億越南盾（按協議簽署當日匯率中間價換算約為人民幣15.87億元）。本次交易不構成關聯交易，亦不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。交易完成後，標的公司將成為麗珠集團合併報表範圍內的附屬公司。

【麗珠醫藥(01513.HK)擬斥資約15.87億元收購一家越南製藥公司64.81%股權】麗珠醫藥(01513.HK)公佈，於2025年5月22日，該公司間接全資附屬LIAN SGP HOLDING PTE. LTD.擬向SK Investment、Sunrise及KBA收購Imexpharm Corporation已發行股份的64.81%，總現金代價為 5,730,815,426,000越南盾(按協議簽署當日匯率換算，約為人民幣15.87億元，港幣17.28 億元)。交割後，目標公司將成為本公司一間間接非全資附屬公司，其財務業績將併入該集團財務報表。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/KBA"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KBA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBA\",,,,,undefined,":{"symbol":"KBA","market":"US","secType":"STK","nameCN":"KraneShares Bosera MSCI China A 50 Connect Index ETF","latestPrice":23.71,"timestamp":1750276800000,"preClose":23.74,"halted":0,"volume":17849,"hourTrading":{"tag":"盘后","latestPrice":23.71,"preClose":23.71,"latestTime":"16:08 EDT","volume":4,"amount":94.49,"timestamp":1750277281229},"delay":0,"floatShares":7200000,"shares":7200000,"eps":0,"marketStatus":"六月節休市","change":-0.03,"latestTime":"06-18 16:00:00 EDT","open":23.78,"high":23.78,"low":23.71,"amount":423951.805,"amplitude":0.002949,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1750406400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":23.74,"sharesOutstanding":7200000,"nav":23.85,"aum":171703475.65,"dividendRate":0.02151,"bidAskSpread":0.000782,"postHourTrading":{"tag":"盘后","latestPrice":23.71,"preClose":23.71,"latestTime":"16:08 EDT","volume":4,"amount":94.49,"timestamp":1750277281229},"volumeRatio":0.7096848578485723,"impliedVol":0.0103,"impliedVolPercentile":0.036},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBA\",,,,,undefined,":{"symbol":"KBA","floatShares":7200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7096848578485723,"shares":7200000,"dividePrice":0.51,"high":23.78,"amplitude":0.002949,"preClose":23.74,"low":23.71,"week52Low":20.635,"pbRate":"--","week52High":31.19,"institutionHeld":0,"latestPrice":23.71,"eps":0,"divideRate":0.02151,"volume":17849,"delay":0,"ttmEps":0,"open":23.78,"prevYearClose":23.45,"prevWeekClose":23.79,"prevMonthClose":23.49,"prevQuarterClose":23.62,"fiveDayClose":23.88,"twentyDayClose":24.19,"sixtyDayClose":23.89},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/KBA\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KBA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537943642","title":"【麗珠集團：擬15.87億元收購越南IMP公司64.81%股份】麗珠集團公告，公司境外全資附屬公司LIAN SGP HOLDING PTE.LTD.擬收購SK Investment Vina III Pte. Ltd.、Sunrise Kim Investment Joint Stock Company及KBA Investment Joint Stock Company合計持有的越南上市公司Imexpharm Corporation 64.81%股份，股權購買價格為57308.15億越南盾（按協議簽署當日匯率中間價換算約為人民幣15.87億元）。本次交易不構成關聯交易，亦不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。交易完成後，標的公司將成為麗珠集團合併報表範圍內的附屬公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537943642","media":"金融界","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537943642?lang=zh_tw&edition=fundamental","pubTime":"2025-05-22 19:27","pubTimestamp":1747913264,"startTime":"0","endTime":"0","summary":"丽珠集团公告，公司境外全资附属公司LIAN SGP HOLDING PTE.LTD.拟收购SK Investment Vina III Pte. Ltd.、Sunrise Kim Investment Joint Stock Company及KBA Investment Joint Stock Company合计持有的越南上市公司Imexpharm Corporation 64.81%股份，股权购买价格为57308.15亿越南盾。本次交易不构成关联交易，亦不构成《上市公司重大资产重组管理办法》规定的重大资产重组。交易完成后，标的公司将成为丽珠集团合并报表范围内的附属公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/22192750597145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","BK4134","BK0028","III","000513","BK0187","KBA","BK0239"],"gpt_icon":0},{"id":"2537191736","title":"【麗珠醫藥(01513.HK)擬斥資約15.87億元收購一家越南製藥公司64.81%股權】麗珠醫藥(01513.HK)公佈，於2025年5月22日，該公司間接全資附屬LIAN SGP HOLDING PTE. LTD.擬向SK Investment、Sunrise及KBA收購Imexpharm Corporation已發行股份的64.81%，總現金代價為 5,730,815,426,000越南盾(按協議簽署當日匯率換算，約為人民幣15.87億元，港幣17.28 億元)。交割後，目標公司將成為本公司一間間接非全資附屬公司，其財務業績將併入該集團財務報表。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537191736","media":"金融界","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537191736?lang=zh_tw&edition=fundamental","pubTime":"2025-05-22 18:12","pubTimestamp":1747908744,"startTime":"0","endTime":"0","summary":"丽珠医药(01513.HK)公布，于2025年5月22日，该公司间接全资附属LIAN SGP HOLDING PTE. LTD.拟向SK Investment、Sunrise及KBA收购Imexpharm Corporation已发行股份的64.81%，总现金代价为 5,730,815,426,000越南盾(按协议签署当日汇率换算，约为人民币15.87亿元，港币17.28 亿元)。交割后，目标公司将成为本公司一间间接非全资附属公司，其财务业绩将并入该集团财务报表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/22181250594186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","BK4139","KBA","BK1574","01477","PTE","01513"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KBA\",params:#limit:5,,,undefined,":[{"date":"2024-12-17","symbol":"KBA","amount":0.51169,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares Bosera MSCI China A 50 Connect Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KBA","amount":0.484915,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares Bosera MSCI China A 50 Connect Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-14","symbol":"KBA","amount":6.251418,"defaultRemindTime":1671028200000,"name":"KraneShares Bosera MSCI China A 50 Connect Index ETF","recordDate":"2022-12-16","payableDate":"2022-12-15","currency":"USD","type":"dividend","dateTimestamp":1670994000000},{"market":"US","date":"2021-12-29","symbol":"KBA","amount":3.446606,"defaultRemindTime":1640788200000,"name":"KraneShares Bosera MSCI China A ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000},{"market":"US","date":"2020-12-29","symbol":"KBA","amount":0.297564,"name":"KraneShares Bosera MSCI China A ETF","recordDate":"2020-12-31","payableDate":"2020-12-30","currency":"USD","type":"dividend","dateTimestamp":1609218000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KBA\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-25","recordDate":"2015-06-29","paymentDate":"2015-06-30","value":0.209594,"currency":"USD"},{"executeDate":"2015-12-28","recordDate":"2015-12-30","paymentDate":"2015-12-31","value":0.414569,"currency":"USD"},{"executeDate":"2015-12-28","recordDate":"2015-12-30","paymentDate":"2015-12-31","value":9.510225,"currency":"USD"},{"executeDate":"2016-06-15","recordDate":"2016-06-17","paymentDate":"2016-06-21","value":0.84991,"currency":"USD"},{"executeDate":"2016-12-20","recordDate":"2016-12-22","paymentDate":"2016-12-23","value":0.460371,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KBA\",market:\"US\",delay:false,,,undefined,":{}}}